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Background/aim: Systemic isotretinoin has been widely considered an effective and safe medical treatment for severe and refractory
acne for nearly 3 decades. However, it also appears to cause undesirable cutaneous side effects. The aim of this study was to prospectively
measure biophysical parameters of skin function among patients with acne vulgaris before and after 3 months of isotretinoin therapy,
including pH, temperature, sebum content, skin hydration, and transepidermal water loss.
Materials and methods: The study cohort consisted of 19 patients with acne vulgaris. Noninvasive methods were used to measure
the biophysical characteristics of forehead skin. All measurements were repeated following the completion of 3 months of systemic
isotretinoin treatment.
Results: Biophysical skin parameter measurements after 3 months of isotretinoin therapy revealed a decrease in the severity of seborrhea.
However, the skin was dry, indicting a decrease in stratum corneum hydration. An increase in skin temperature was also determined.
Conclusion: Treatment with systemic isotretinoin reduces sebum secretion and stratum corneum hydration and increases skin
temperature, suggesting that isotretinoin may partially improve the biophysical characteristics of the skin among patients with acne
vulgaris.
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1. Introduction
Acne is a frequently self-limiting intermittent or chronic
inflammatory condition affecting the pilosebaceous glands
of the skin, most commonly occurring in adolescents.
The clinical characteristics of acne include erythematous
papules, comedones, pustules, and occasionally
pseudocysts or nodules. A number of conventional
systemic and topical treatments have been demonstrated
to effectively reduce lesions. However, oral isotretinoin
therapy has been shown to dramatically improve the
treatment and management of refractory or severe acne.
Oral isotretinoin therapy may result in extended periods
of disease remission or resolution (1–4). Oral isotretinoin
is effective in the treatment of acne vulgaris as a result of
direct suppression of the microcomedone and sebaceous
glands (5).
The skin is a multifunctional organ and the largest
in the body. It absorbs ultraviolet radiation, combats

microorganism invasion and chemical penetration, and
regulates the passage of water and electrolytes. The skin
also plays a major role in thermoregulation, in addition
to performing immunological, sensory, and autonomic
functions. It is essential to be aware of the physiological,
chemical, and biophysical characteristics of the skin if the
correct approach to the management of dermatological
diseases is to be identified. However, the effects of genetic
and environmental factors on the majority of cutaneous
characteristics must also be considered (6).
Despite the widespread use of isotretinoin in the
treatment of nodular-cystic acne and refractory acne, few
studies have examined the effects of systemic isotretinoin
therapy on the biophysical parameters of skin (7). This
study investigated biophysical changes in the skin of
patients with acne vulgaris and the effect of treatment
on these changes. Skin humidity, transepidermal water
loss (TEWL), sebum content, temperature, and pH were
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determined using noninvasive procedures in acne patients
before and after isotretinoin therapy.
2. Materials and methods
2.1. Patients
The experimental procedures were conducted in the
Dermatology Department of the Faculty of Medicine,
Erciyes University, Kayseri, Turkey. The Erciyes University
Medical School Ethics Committee reviewed and approved
the study protocol. All study participants provided
informed consent.
The subjects included 19 patients aged ≥18 years who
presented to the outpatient clinic with moderate to severe
acne vulgaris. None of the participating patients had
benefited from previous acne treatments and they had not
received any acne medication during the previous 30 days.
All patients were provided with materials informing
them of the potential side effects of isotretinoin. A
daily dose of 0.5–0.75 mg/kg was applied as the initial
treatment. All patients were evaluated at regular intervals.
Laboratory and clinical examinations were completed
prior to treatment and at monthly intervals following the
initiation of therapy.
All application of topical moisturizing agents and
cosmetics was withdrawn for 48 h prior to experimental
evaluations. Biophysical measurements of forehead skin
were repeated at 3 months after the initiation of therapy.
2.2. Analytical methods
Noninvasive methods were used to determine the
biophysical properties of forehead skin. This included
use of a Tewameter (TM 210), Sebumeter (SM 810),
Corneometer (CM 825) and pH meter (PH 900) (Courage
+ Khazaka Electronic GmbH, Cologne, Germany) (8–10).
Stratum corneum hydration status was calculated
after measurement of electrical capacitance using the
Corneometer (CM 825). The dielectric constant is
dependent on the level of skin hydration, resulting in
changes in tissue capacitance when the probe is pressed
to the forehead at a pressure of 7.1 N/cm2. Specific units of
measurement (11–14) are equivalent to 0.02 mg/cm2 water
at 20 nm below the skin surface.
Quantitative determination of skin surface lipids,
primarily corneal lipids and sebum, was completed
using the Sebumeter (SM 810). This device quantifies
light transmission through a sebum-coated sheet of
plastic stained for lipids; the procedure is not influenced
by environmental humidity. The Sebumeter is applied
to the skin for 0.5 min at a constant force of 9.4 N/cm2.
The sebum concentration is quantified as μg/cm (11,12).
Sebum content was measured at baseline, prior to the
application of any facial wipes or cleansers.
An evaporation meter was used to determine TEWL
(Tewameter TM 210). The recommendations of the
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European Group for Efficacy Measurements on Cosmetics
and Other Topical Products were used in all cases
(expressed in g m–2 h–1) (15). The same device was used to
measure skin temperature.
A pH meter was used to measure skin pH (PH 900).
The same investigator performed all measurements
(EÇ). No information regarding the biophysical properties
of the skin was provided to the study participants. All
measurements were taken from a representative seborrheic
area, the forehead.
2.3. Measurement conditions
Room temperature was set to 20–22 °C and ambient
humidity was maintained at 40%–45%. Prior to
measurement, patients were held in the test room for
30 min, with the measurement sites uncovered, to allow
the skin to adapt to room temperature and humidity.
Measurements were performed between 1400 and 1600
hours to exclude the effects of diurnal variation.
2.4. Statistical analysis
The results are reported as mean ± standard deviation.
The characteristics analyzed diverged significantly from
normal distribution. The nonparametric Wilcoxon paired
test was therefore used to compare our findings before
and after 3 months of isotretinoin therapy. P < 0.05 was
considered statistically significant.
3. Results
The mean age and sex distributions did not differ
significantly among the patients (20.47 ± 3.27 years, 9
males and 10 females).
There were no significant changes in TEWL and pH
after 3 months of isotretinoin therapy. The degree of skin
sebum content was reduced from the value of 257.7 ±
67.5 μg/cm2 to 64.9 ± 63.4 μg/cm2. The degree of stratum
corneum hydration significantly decreased; its mean was
57.9 ± 17.6 mg/cm2 prior to treatment and 46.1 ± 14.8 mg/
cm2 after 3 months of treatment. The skin temperature
significantly increased from 24.3 ± 2.02 °C to 26.5 ± 2.6 °C.
The mean value differences for each parameter are shown
in the Table.
4. Discussion
Isotretinoin has been used as a safe and effective
medication for the management of severe and refractory
acne for nearly 30 years. This drug potently modulates all
major factors in the pathogenesis of acne and is the only
approach with the potential to produce a permanent cure
or long-term remission of acne (1,2,5). Previous studies
have emphasized the possibility of numerous undesirable
side effects during isotretinoin treatment. Isotretinoin
tolerance is reported to be highly dose-dependent. When
isotretinoin is used at daily doses higher than 0.5 mg/kg,
lesions of the skin and mucous membranes are observed
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Table. Results of skin measurements before and after 3 months of treatment.
Before treatment
n = 19
Mean ± SD

After 3 months of treatment
n = 19
Mean ± SD

P

Sebum content (Sebumeter units; µg/cm2)

257.7 ± 67.5

64.9 ± 63.4

<0.001

TEWL (Tewameter units; g m h )

29.6 ± 20.9

29.9 ± 13.1

0.6

pH

5.9 ± 0.7

6.2 ± 1.08

0.38

Skin capacitance (Corneometer units; 0.02 mg/cm )

57.9 ± 17.6

46.1 ± 14.8

0.04

Temperature (°C)

24.3 ± 2.02

26.5 ± 2.6

<0.01

Measurements

–2

–1

2

in almost all patients. Previous studies reported varying
degrees of cheilitis in 96% of patients, and some authors
suggested that this represents an accurately selected dose
(16). Other common side effects include cutaneous and
mucous dryness, conjunctivitis, pruritus, and sensitivity
to ultraviolet radiation, as well as sparse hair and hair
thinning. Variations in basic laboratory test results, such
as blood cell count, transaminases, bilirubin, blood lipids,
and alkaline phosphatase levels, have been observed in
some cases. This may also indicate the need to lower the
dose administered or the addition to treatment of other
medicaments (3,17). Our patients also reported side
effects, including dry skin, burning sensations, and drying
of the mucous membranes. Skin dryness in treated patients
directed our attention toward the skin barrier function.
Isotretinoin treatment reduces the size and secretions of
the sebaceous glands (7,18,19). Sebumeter measurements
revealed a significant decrease in the degree of cutaneous
sebum content, as also confirmed by previous studies
(7,18,19).
Kmieć et al. (7) reported a decrease in stratum corneum
hydration and an increase in TEWL values in patients
with acne receiving isotretinoin therapy. We determined
a significant decrease in stratum corneum hydration, but
no difference in TEWL values. The absence of a difference
in TEWL values may possibly be due to treatment not
yet having been completed. Disruption of the epidermal
barrier, resulting in a decrease in stratum corneum
hydration, also causes the widespread skin discomfort
described by patients.
We determined an increase in skin temperature. Kmieć
et al. (7) did not assess posttreatment skin temperature,
but they did report an increase in the erythema levels they
measured. Thinning of the skin and increased erythema

during isotretinoin therapy may be responsible for the
increase in skin temperature.
Studies have reported a rise in pH following isotretinoin
therapy (7). In our study, pH values after 3 months of oral
isotretinoin therapy rose by a mean 0.3 units, although this
increase was not statistically significant. Longer periods
of systemic isotretinoin therapy in acne vulgaris may be
required to significantly alter these biophysical parameters.
This study is limited by the relatively small sample size,
the evaluation of skin biophysical parameters at a single
skin site, and the fact that no measurements were made at
the completion of therapy.
Our findings confirm that adverse cutaneous and
mucous membrane reactions may be seen during
isotretinoin therapy, and these were observed in the great
majority of patients. Such reactions and poor tolerance of
them have been reported by a number of previous studies
(3,5,7,17,18). We therefore recommend that patients be
given suitable skin care instructions during isotretinoin
therapy. Formulations that moisturize the skin should be
preferred, and care should be taken that cleaning agents do
not leave the skin dry.
In conclusion, systemic isotretinoin therapy resulted
in decreased sebum content, stratum corneum hydration,
and increased skin temperature after 3 months, but no
change was observed in the other biophysical parameters
measured. These results suggest that systemic isotretinoin
may improve the biophysical characteristics of the skin
through both direct and indirect mechanisms. Further
long-term and large-scale studies evaluating the effects
of acne vulgaris treatment on both functional and
histomorphological changes may be required to fully
characterize the effects of systemic isotretinoin on skin
physiology.

1643

ÇÖLGEÇEN et al. / Turk J Med Sci
References
1.

Plewig G. Acne and rosacea. In: Burgdorf WHC, Plewing G,
Wolff HH, Landthaler M, editors. Braun-Falco’s Dermatology.
3rd ed. Berlin, Germany: Springer-Verlag; 2009. pp. 993-1017.

2.

Zaenglein AL, Graber EM, Thiboutot DM, Strauss JS. Acne
vulgaris and acneiform eruptions. In: Wolff K, Goldsmith LA,
Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick’s
Dermatology in General Medicine. 7th ed. New York, NY,
USA: McGraw Hill; 2008. pp. 690-703.

3.

Brito Mde F, Sant’Anna IP, Galindo JC, Rosendo LH, Santos JB.
Evaluation of clinical adverse effects and laboratory alterations
in patients with acne vulgaris treated with oral isotretinoin. An
Bras Dermatol 2010; 85: 331-337.

4.

Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet
2012; 379: 361-372.

5.

Chivot M. Retinoid therapy for acne. A comparative review.
Am J Clin Dermatol 2005; 6: 13-19.

6.

Firooz A, Sadr B, Babakoohi S, Sarraf-Yazdy M, Fanian F,
Kazerouni-Timsar A, Nassiri-Kashani M, Naghizadeh MM,
Dowlati Y. Variation of biophysical parameters of the skin
with age, gender, and body region. ScientificWorldJournal
2012;2012:386936.

7.

Kmieć ML, Pajor A, Broniarczyk-Dyła G. Evaluation of
biophysical skin parameters and assessment of hair growth in
patients with acne treated with isotretinoin. Postepy Dermatol
Alergol 2013; 30: 343-349.

8.

Rode B, Ivens U, Serup J. Degreasing method for the seborrheic
areas with respect to regaining sebum excretion rate to casual
level. Skin Res Technol 2000; 6: 92-97.

9.

Barel AO, Clarys P. Measurement of epidermal capacitance. In:
Serup J, Jemec G, editors. Handbook of Non-Invasive Methods
and the Skin. Boca Raton, FL, USA: CRC Press; 1995. pp. 165170.

10.

Sator PG, Schmidt JB, Hönigsmann H. Comparison of
epidermal hydration and skin surface lipids in healthy
individuals and in patients with atopic dermatitis. J Am Acad
Dermatol 2003; 48: 352-358.

1644

11.

Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette
G. Does hormonal skin aging exist? A study of the influence
of different hormone therapy regimens on the skin of
postmenopausal women using non-invasive measurement
techniques. Dermatology 1996; 193: 289-294.

12.

Wilhelm KB, Cua AB, Maibach HI. Skin aging-effect on
transepidermal water loss, stratum corneum hydration, skin
surface pH, and casual sebum content. Arch Dermatol 1991;
127: 1806-1809.

13.

Schmidt JB, Binder M, Macheiner W, Kainz C, Gitsch
G, Bieglmayer C. Treatment of skin ageing symptoms in
perimenopausal females with estrogen compounds. A pilot
study. Maturitas 1994; 20: 25-30.

14.

Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE. Skin
water-holding capacity and transdermal estrogen therapy for
menopause: a pilot study. Maturitas 1995; 22: 151-154.

15.

Rogiers V; EEMCO Group. EEMCO guidance for the
assessment of transepidermal water loss in cosmetic sciences.
Skin Pharmacol Appl Skin Physiol 2001; 14: 117-128.

16.

Cyrulnik AA, Viola KV, Gewirtzman AJ, Cohen SR. High-dose
isotretinoin in acne vulgaris: improved treatment outcomes
and quality of life. Int J Dermatol 2012; 51: 1123-1130.

17.

Karadağ AS, Çalka Ö, Akdeniz N. Evaluation of side effects of
isotretinoin in 150 patients with acne vulgaris. Türkderm 2011;
45: 37-42.

18.

Ellis CN, Krach KJ. Uses and complications of isotretinoin
therapy. J Am Acad Dermatol 2001; 45: 150-157.

19.

Janiczek-Dolphin N, Cook J, Thiboutot D, Harness J, Clucas
A. Can sebum reduction predict acne outcome? Br J Dermatol
2010; 163: 683-688.

